The Wnt Signaling Pathway Effector TCF7L2 Mediates Olanzapine-Induced Weight Gain and Insulin Resistance.

Front Pharmacol · 2018 · PMC5911481 · PMID 29713286

Europe PMC DOI

hedged sentence

0.0630

closest p · 1.3× alpha

0.0630

boldest claim

The sentences

an increasing trendp = 0.063so close (0.05 < p ≤ 0.1)

Although no significant difference in AUCg was observed between the olanzapine and control groups, an increasing trend in blood glucose was evident in the olanzapine group at OGTT 30 min ( p = 0.063).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.